Literature DB >> 18922893

Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.

Rubén A Bartolomé1, Natalia Wright, Isabel Molina-Ortiz, Francisco J Sánchez-Luque, Joaquin Teixidó.   

Abstract

The GTPase RhoA is a downstream target of heterotrimeric G(13) proteins and plays key roles in cell migration and invasion. Here, we show that expression in human melanoma cells of a constitutively active, GTPase-deficient Galpha(13) form (G(alpha)(13)QL) or lysophosphatidylcholine (LPC)-promoted signaling through G(alpha)(13)-coupled receptors led to a blockade of chemokine-stimulated RhoA activation and cell invasion that was rescued by active RhoA. Melanoma cells expressing G(alpha)(13)QL or cells stimulated with LPC displayed an increase in p190RhoGAP activation, and defects in RhoA activation and invasion were recovered by knocking down p190RhoGAP expression, thus identifying this GTPase-activating protein (GAP) protein as a downstream G(alpha)(13) target that is responsible for these inhibitory responses. In addition, defective stress fiber assembly and reduced migration speed underlay inefficient invasion of G(alpha)(13)QL melanoma cells. Importantly, G(alpha)(13)QL expression in melanoma cells led to impairment in lung metastasis associated with prolonged survival in SCID mice. The data indicate that G(alpha)(13)-dependent downstream effects on RhoA activation and invasion tightly depend on cell type-specific GAP activities and that G(alpha)(13)-p190RhoGAP signaling might represent a potential target for intervention in melanoma metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922893     DOI: 10.1158/0008-5472.CAN-08-0561

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

Review 2.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

Review 3.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

4.  Gα13 mediates human cytomegalovirus-encoded chemokine receptor US28-induced cell death in melanoma.

Authors:  Shripad Joshi; Christian Wels; Christine Beham-Schmid; Mizuho Fukunaga-Kalabis; Sheri L Holmen; Marcus Otte; Meenhard Herlyn; Maria Waldhoer; Helmut Schaider
Journal:  Int J Cancer       Date:  2015-03-16       Impact factor: 7.396

5.  miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma.

Authors:  Marta Díaz-Martínez; Lucía Benito-Jardón; Lola Alonso; Lisa Koetz-Ploch; Eva Hernando; Joaquin Teixidó
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

6.  Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells.

Authors:  Pablo Hernández-Varas; Georgina P Coló; Ruben A Bartolomé; Andrew Paterson; Iria Medraño-Fernández; Nohemí Arellano-Sánchez; Carlos Cabañas; Paloma Sánchez-Mateos; Esther M Lafuente; Vassiliki A Boussiotis; Staffan Strömblad; Joaquin Teixidó
Journal:  J Biol Chem       Date:  2011-03-26       Impact factor: 5.157

7.  Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.

Authors:  C Lecointre; L Desrues; J E Joubert; N Perzo; P-O Guichet; V Le Joncour; C Brulé; M Chabbert; R Leduc; L Prézeau; A Laquerrière; F Proust; P Gandolfo; F Morin; H Castel
Journal:  Oncogene       Date:  2015-01-19       Impact factor: 9.867

8.  Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA.

Authors:  Isabel Molina-Ortiz; Rubén A Bartolomé; Pablo Hernández-Varas; Georgina P Colo; Joaquin Teixidó
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

9.  Aryl-hydrocarbon receptor-dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene.

Authors:  Chih-Cheng Chang; Shih-Ying Tsai; Heng Lin; Hsiao-Fen Li; Yi-Hsuan Lee; Ying Chou; Chih-Yu Jen; Shu-Hui Juan
Journal:  Cell Mol Life Sci       Date:  2009-08-01       Impact factor: 9.261

Review 10.  Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.

Authors:  Adit Ben-Baruch
Journal:  Cell Adh Migr       Date:  2009-10-05       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.